|
|
||||||||
Departments of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
We recently reported that cADP-ribose
(cADPR) and ADP-ribose (ADPR) play an important role in the regulation
of the Ca2+-activated K+ (KCa)
channel activity in coronary arterial smooth muscle cells (CASMCs). The present study determined whether these novel
signaling nucleotides participate in 11,12-epoxyeicosatrienoic acid
(11,12-EET)-induced activation of the KCa channels in
CASMCs. HPLC analysis has shown that 11,12-EET increased the production
of ADPR but not the formation of cADPR. The increase in ADPR production
was due to activation of NAD glycohydrolase as measured by a conversion
rate of NAD into ADPR. The maximal conversion rate of NAD into ADPR in
coronary homogenate was increased from 2.5 ± 0.2 to 3.4 ± 0.3 nmol · min
1 · mg
protein
1 by 11,12-EET. The regioisomers of 8,9-EET,
11,12-EET, and 14,15-EET also significantly increased ADPR
production from NAD. Western blot analysis and immunoprecipitation
demonstrated the presence of NAD glycohydrolase, which mediated
11,12-EET-activated production of ADPR. In cell-attached patches,
11,12-EET (100 nM) increases KCa channel activity by
5.6-fold. The NAD glycohydrolase inhibitor cibacron blue 3GA (3GA, 100 µM) significantly attenuated 11,12-EET-induced increase in the
KCa channel activity in CASMCs. However, 3GA had no effect
on the KCa channels activity in inside-out patches. 11,12-EET produced a concentration-dependent relaxation of
precontracted coronary arteries. This 11,12-EET-induced vasodilation
was substantially attenuated by 3GA (30 µM) with maximal inhibition
of 57%. These results indicate that 11,12-EET stimulates the
production of ADPR and that intracellular ADPR is an important
signaling molecule mediating 11,12-EET-induced activation of the
KCa channels in CASMCs and consequently results in
vasodilation of coronary artery.
nicotinamide adenine dinucleotide glycohydrolase; K+ channels; epoxyeicosatrienoic acid; endothelium-derived hyperpolarization factor
This article has been cited by other articles:
![]() |
H. C. Hercule, B. Salanova, K. Essin, H. Honeck, J. R. Falck, M. Sausbier, P. Ruth, W.-H. Schunck, F. C. Luft, and M. Gollasch Vascular: The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK {alpha} channel subunit in rodents Exp Physiol, November 1, 2007; 92(6): 1067 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Le Quere, E. Plee-Gautier, P. Potin, S. Madec, and J.-P. Salaun Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides J. Lipid Res., August 1, 2004; 45(8): 1446 - 1458. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |